XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF REVENUE FROM PRODUCT SALES AND ROYALTIES (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Product Information [Line Items]    
Total Net Revenue $ 23,434,096 $ 18,536,638
Soft Tissue Repair Products [Member]    
Product Information [Line Items]    
Total Net Revenue 20,532,440 16,082,292
Bone Fusion Products [Member]    
Product Information [Line Items]    
Total Net Revenue $ 2,901,656 $ 2,454,346